Clinical utility of valsartan in treatment of children and adolescents with high blood pressure

References

• FlynnJTSuccesses and shortcomings of the FDA Modernization ActAm J Hypertens20031688989114553972
   PubMed Web of Science ®Google Scholar
• Novartis Pharmaceuticals CorporationDiovan® prescribing informationEast Hanover, NJNovartis Pharmaceuticals Corporation112007
   Google Scholar
• National High Blood Pressure Education Program Working Group on Hypertension Control in Children and AdolescentsUpdate on the 1987 task force report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education ProgramPediatrics1996986496588885941
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and AdolescentsThe fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescentsPediatrics2004114Suppl 212215231900
   PubMed Web of Science ®Google Scholar
• MunterPHeJCutlerJAWildmanRPWheltonPKTrends in blood pressure among children and adolescentsJAMA20042912107211315126439
   PubMed Web of Science ®Google Scholar
• HajjarIKotchenTTrends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000JAMA200329019920612851274
   PubMed Web of Science ®Google Scholar
• HansenMLGunnPWKaelberDCUnderdiagnosis of hypertension in children and adolescentsJAMA200729887487917712071
   PubMed Web of Science ®Google Scholar
• BeckettLARosnerBRocheAFSerial changes in blood pressure from adolescence into adulthoodAm J Epidemiol1992135116611771632426
   PubMed Web of Science ®Google Scholar
• RobinsonRFNahataMCBatiskyDLPharmacologic treatment of chronic pediatric hypertensionPaediatr Drugs20057274015777109
   PubMedGoogle Scholar
• KaveyREDanielsSRFlynnJTManagement of high blood pressure in children and adolescentsCardiol Clin20102859760720937444
   PubMed Web of Science ®Google Scholar
• BalkrishnanRPhatakHGleimGKarveSAssessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertensionJ Hum Hypertens20092342042519052566
   PubMed Web of Science ®Google Scholar
• KotsisVStabouliSPapakatsikaSRizosZParatiGMechanisms of obesity-induced hypertensionHypertens Res2010333893
   Web of Science ®Google Scholar
• WühlETrivelliAPiccaSStrict blood-pressure control and progression of renal failure in childrenN Engl J Med20093611639165019846849
   PubMed Web of Science ®Google Scholar
• van HooftIMGrobbeeDEDerkxFHde LeeuwPWSchalekampMAHofmanARenal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parentsN Engl J Med1991324130513112017226
   PubMed Web of Science ®Google Scholar
• EganBMBasileJNRehmanSUPlasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: A randomized controlled trialAm J Hypertens20092279280119373213
   PubMed Web of Science ®Google Scholar
• Diovan® (valsartan) tabletsPrescribing informationEast Hanover, NJNovartis Pharmaceuticals Corporation2008 Available from: http://www.pharma.us.novartis.com/products/name/diovan.jspAccessed February 16, 2011
   Google Scholar
• BlackHRBaileyJZappeDSamuelRValsartan: More than a decade of experienceDrugs2009692393241419911855
   PubMed Web of Science ®Google Scholar
• FleschGMullerPLloydPAbsolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in manEur J Clin Pharmacol1997521151209174680
   PubMed Web of Science ®Google Scholar
• BlumerJBatiskyDLWellsTShiVSolar-YohaySSunkaraGPharmacokinetics of valsartan in pediatric and adolescent subjects with hypertensionJ Clin Pharmacol20094923524119179299
   PubMed Web of Science ®Google Scholar
• WaldmeierFMuellerPHFleschGPharmacokinetics, disposition and biotransformation of valsartan (CGP 48933) in healthy male volunteers after a single oral dose of 80 mg 14C-radiolabelled preparationXenobiotica19972759719041679
   PubMed Web of Science ®Google Scholar
• HabtemariamBSallasWSunkaraGKernSJarugulaVPillaiGPopulation pharmacokinetics of valsartan in pediatricsDrug Metab Pharmacokinet20092414515219430170
   PubMed Web of Science ®Google Scholar
• FlynnJTMeyersKENetoJPPediatric Valsartan Study GroupEfficacy and safety of the angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 yearsHypertension20085222222818591457
   PubMed Web of Science ®Google Scholar
• WellsTBlumerJMeyersKEThe Valsartan Pediatric Hypertension Study GroupYears with hypertension. Effectiveness and safety of valsartan in children aged 6 to 16J Clin Hypertens (Greenwich)20111335736521545397
   PubMed Web of Science ®Google Scholar
• JamersonKAZappeDHCollinsLThe time to blood pressure (BP) control by initiating antihypertensive therapy with a higher dose of valsartan (160 mg) or valsartan/hydrochlorothiazide compared to low-dose valsartan (80 mg) in the treatment of hypertension: The VELOCITY studyJ Clin Hypertens200795 Suppl AA166
   Google Scholar
• PoolJLGlazerRChiangYTGatlinMDose-response efficacy of valsartan, a new angiotensin II receptor blockerJ Hum Hypertens19991327528110333347
   PubMed Web of Science ®Google Scholar
• ShahinfarSCanoFSofferBAA double-blind, dose-response study of losartan in hypertensive childrenAm J Hypertens2005182 Pt 118319015752945
   PubMed Web of Science ®Google Scholar
• LubranoRSosciaFElliMRenal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuriaPediatrics2006118e833e83816923922
   PubMed Web of Science ®Google Scholar
• MeierCMSimonettiGDGhigliaSPalatability of angiotensin II antagonists among nephropathic childrenBr J Clin Pharmacol20076362863117302913
   PubMed Web of Science ®Google Scholar
• DestroMScabrosettiRVanasiaAComparative efficacy of valsartan and olmesartan in mild-to-moderate hypertension: Results of 24-hour ambulatory blood pressure monitoringAdv Ther200522324315943220
   PubMed Web of Science ®Google Scholar
• HermidaRCCalvoCAyalaDEAdministration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjectsHypertension20034228329012874091
   PubMed Web of Science ®Google Scholar
• TiroshAAfekARudichAProgression of normotensive adolescents to hypertensive adults: A study of 26,980 teenagersHypertension20105620320920547973
   PubMed Web of Science ®Google Scholar